NCT00749970
Completed
N/A
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Schizophrenia
- Sponsor
- AstraZeneca
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- SWN-K
- Status
- Completed
- Last Updated
- 15 years ago
Overview
Brief Summary
Observational, short-term prospective, multicenter study to assess psychometric properties of the Spanish version of SWN-K scale in patients with schizophrenia.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with a diagnosis of schizophrenia, schizoaffective disorder, or schizophreniform disorder (DSM-IV TR criteria)
- •Stabilized out-patients
- •Under treatment with an oral antipsychotic drug
Exclusion Criteria
- •Administration of a depot antipsychotic drug
- •Participation in another clinical trial within 4 weeks prior to enrolment into this study
Outcomes
Primary Outcomes
SWN-K
Time Frame: 7 days
PANSS
Time Frame: 7 days
Secondary Outcomes
- CGI-I(7 days)
Study Sites (2)
Loading locations...
Similar Trials
Completed
N/A
Spanish Validation of Tool Questionnaire to Assess Patients´Perception About Antipsychotic TreatmentSchizophreniaBipolar DisorderNCT00692133AstraZeneca250
Completed
N/A
Psycometric Properties of Pushing ScaleBalanceFunctionalityNCT03674268Guadarrama Hospital120
Completed
N/A
Validation of the Spanish Version of the Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) in ChilePsychological DistressNCT04122079Pontificia Universidad Catolica de Chile1,120
Completed
N/A
A Study Run At Multiple Study Sites to Test Whether the SAMANTA Questionnaire That is Used to Diagnose Heavy Menstrual Bleeding (HMB), Can Also Be Used to Assess Changes of Severity of HMB in Women with HMB Who Are Treated During 12 Months with a Chronic Hormonal TreatmentMenorrhagiaNCT03751800Bayer422
Completed
N/A
Study of Mental Care in SpainSchizophreniaNCT00824031AstraZeneca76